Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
27.7M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
-310K
-
Total reported value, excl. options
-
$328M
-
Value change
-
-$8.74M
-
Number of buys
-
31
-
Number of sells
-
-20
-
Price
-
$23.93
Significant Holders of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB) as of Q2 2017
58 filings reported holding ANAB - ANAPTYSBIO, INC - Common Stock, $0.01 par value as of Q2 2017.
ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
of 27.7M outstanding shares and own 49.43% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (3.69M shares), Novo Holdings A/S (3.03M shares), BVF INC/IL (1.66M shares), PERCEPTIVE ADVISORS LLC (952K shares), Cormorant Asset Management, LLC (799K shares), DEERFIELD MANAGEMENT CO (553K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (532K shares), BlackRock Inc. (302K shares), FRANKLIN RESOURCES INC (279K shares), and Artal Group S.A. (250K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.